I think pharma is good vertical, for long term can i buy this vertical. Please suffest me should i buy individual shares or fo for MF. and if MF which you will suggest me?
Our finance ministers step towards relaxation of tax towards R&D Will definitly motovate the real R&d Players in the market.His step towrds relaxation of Duties of free sample will really help the marketting Departmet to get rid of their big Head Ache. Since development cost and clinical trial cost in India is very less compare to developed countries. Also Tax relasation and duty reduction on equipments will help Indian players to procure imported equipments at low cost. All this definately improve Pharmaceutical sector in india. vasanth.M, B.Pharm,M.B.A,Sona School of management, kmvasanth@rediffmail.com
Its good time aheade for pharmaceutical indusatry who involved in Research and Development activity. Now good Pharmaceutical organisation should focus aggresively on development of New Drug Delivery systems for exsisting molecule, so that it can came in market soon and AAM ADMI can get best medicine at affordable rates. Since development cost and clinical trial cost in India is very less compare to developed countries. Also Tax relasation and duty reduction on equipments will help Indian players to procure imported equipments at low cost. All this definately improve Pharmaceutical sector and in india will definately helpful for Research oriented firms like Ranbaxy Lab, Cipla, Zydus Cadila, Dr. Reddys, Nicholas Piramal etc.
GREAT JOB FM.
From Vijayendra Redasani M.Pharm- Industrial Pharmacy Reseach Scientiest
